- Home
- CME
CME
CME Group Inc.
as 07-04-2025 12:31pm EST
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
| Founded: | 1898 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 102.5B | IPO Year: | 2002 |
| Target Price: | $259.44 | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | Hold | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 9.94 | EPS Growth: | 13.21 |
| 52 Week Low/High: | $193.17 - $290.79 | Next Earning Date: | 07-23-2025 |
| Revenue: | $6,274,100,000 | Revenue Growth: | 11.73% |
| Revenue Growth (this year): | 9.26% | Revenue Growth (next year): | 4.04% |
Stock Insider Trading Activity of CME Group Inc. (CME)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Carey Charles P | CME | Director | Jun 10 '25 | Sell | $265.36 | 500 | $132,676.50 | 4,900 | |
| Kaye Daniel G | CME | Director | May 22 '25 | Sell | $282.42 | 500 | $141,209.65 | 3,668 | |
| Marcus Jonathan L | CME | Sr MD General Counsel | May 20 '25 | Sell | $277.50 | 390 | $108,225.00 | 6,708 | |
| Lockett Phyllis M | CME | Director | May 19 '25 | Sell | $277.88 | 1,060 | $294,552.80 | 3,108 | |
| GEPSMAN MARTIN J | CME | Director | May 15 '25 | Sell | $273.17 | 300 | $81,951.00 | 24,767 | |
| Carey Charles P | CME | Director | May 15 '25 | Sell | $272.56 | 3,000 | $817,680.00 | 4,900 | |
| Suskind Dennis | CME | Director | Apr 29 '25 | Sell | $271.28 | 1,000 | $271,280.00 | 2,915 |
Latest CME Group Inc. News
CME Breaking Stock News: Dive into CME Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Could CME Group's FX Tape+ be the Key to a More Transparent FX Market?
Barchart
3 days ago
CME Group's Quarterly Earnings Preview: What You Need to Know
Insider Monkey
3 days ago
CME Group to Launch FX Tape+ for Enhanced Transparency in Foreign Exchange Markets
MT Newswires
3 days ago
Sector Update: Financial Stocks Rise Thursday Afternoon
Bloomberg
3 days ago
Trump Visits Iowa While 2028 Republicans Wait for Their Chance
The Wall Street Journal
3 days ago
That Sound You Hear Is Rate-Cut Odds Collapsing: Reactions to the Jobs Report
The Wall Street Journal
4 days ago
Traders Bet on Fewer Rate Cuts After Solid Jobs Report
MT Newswires
4 days ago
KKR Named Morgan Stanley's Top Pick Amid Improving Macro Conditions, Normalizing Volatility
Compare CME vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CME CME Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.